Prestige Consumer Healthcare Inc. PBH revenue by segment, product and geography
In its fiscal year ending 2026-03-31, Prestige Consumer Healthcare Inc. reported revenue across 2 business segments; the largest, North American OTC Healthcare, was $914M, 83.9% of the filed sum (-4.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- North American OTC Healthcare$914M83.9%-4.8% yoy
- International OTC Healthcare$175M16.1%-1.5% yoy
Members sum to the consolidated $1.09B for this period.
- Product$1.08Bshare n/a-4.6% yoy
- Gastrointestinal$260Mshare n/a+1.5% yoy
- Womens Health$228Mshare n/a-3.8% yoy
- Eye And Ear Care$143Mshare n/a-22.0% yoy
- Dermatologicals$126Mshare n/a-2.3% yoy
- Analgesics$114Mshare n/a-3.2% yoy
- Cough And Cold$102Mshare n/a-4.1% yoy
- Oral Care$101Mshare n/a+6.3% yoy
- +2 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$850M78.1%-5.3% yoy
- Outside the United States$238M21.9%-0.8% yoy
Members sum to the consolidated $1.09B for this period.
- North American OTC Healthcare$236M83.2%-1.4% yoy
- International OTC Healthcare$47.7M16.8%-7.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.